The platelet-to-lymphocyte ratio (PLR) and C-reactive protein (CRP), which are two inflammation-related biomarkers, have been confirmed to be prognostic indicators in early gastric cancer, gastrointestinal cancers, and CRC [6–8]. The gene discussed is CRP; the disease is colorectal carcinoma.